Executive Summary
Swiss exports rose seasonally adjusted by 13.4 percent in May 2026, following stagnation in April. Imports grew by 3.4 percent (previous month: –2.9 percent). The main drivers were chemical-pharmaceutical products and trade with Europe. The trade balance reached 5.6 billion francs, the highest surplus in the last twelve months. The data was published on June 18, 2026 by the Swiss State Secretariat for Economic Affairs.
People
- No individuals named
Topics
- Swiss foreign trade
- Chemical and pharmaceutical industry
- Export statistics
- Trade balance
Clarus Lead
The strong export growth signals an economic recovery in Swiss industry following the stagnation phase. The dominance of the chemical-pharma sector underscores the structural dependence of the Swiss economy on this sector. The rise in the trade balance to its highest level in a year points to improved international competitiveness – relevant for the SNB's currency and monetary policy as well as for investment decisions.
Detailed Summary
The 13.4 percent export growth follows a stagnation phase in April and marks a clear acceleration. Particularly noteworthy is the breadth of growth: While exports increase sharply, imports also stabilize (after a decline in the previous month of –2.9 percent) with a moderate increase of 3.4 percent.
Chemical-pharmaceutical products were the main engine in both trade directions. This sector accounts for a substantial share of Swiss value creation and is highly competitive internationally. Trade with Europe was also a growth driver, indicating stable demand from the main sales market. The trade balance of 5.6 billion francs is the best value since June 2025 and shows an export surplus momentum.
Key Findings
- Swiss exports rose in May 2026 by 13.4 percent (seasonally adjusted) following stagnation in the previous month
- Chemical-pharma sector was the main growth driver in both exports and imports
- Trade balance reached 5.6 billion francs, the highest value in 12 months
Critical Questions
Data Quality & Seasonal Adjustment: How robust is the seasonal adjustment for May, and were extraordinary supply chain effects (e.g., catch-up effects from April) taken into account?
Industry Concentration: To what extent is this growth concentrated among a few large chemical-pharma companies, and how representative is it for the overall economy?
Europe Dependence: Which European countries/sectors are driving the growth? Is there a risk from over-concentration on a single market?
Sustainability: Is this a structural trend or a statistical outlier following stagnation? What is the forecast for June/July 2026?
Import Dynamics: Why did imports rise only by 3.4 percent while exports grew by 13.4 percent? Does this indicate raw material shortages or price effects?
Currency Effects: Did franc appreciation/depreciation play a role in the export figures?
Source List
Primary Source: Press Release: May 2026 – Chemical-Pharma Delivers Strong Export Boost – State Secretariat for Economic Affairs (SECO), June 18, 2026
Verification Status: ✓ June 18, 2026
This text was created with the support of an AI model. Editorial Responsibility: clarus.news | Fact-Check: June 18, 2026